The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Volkow, N. D.
* Articles by Dewey, S. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Volkow, N. D.
* Articles by Dewey, S. L.

Am J Psychiatry 1993; 150:417-422
Copyright © 1993 by American Psychiatric Association


REGULAR ARTICLES

Decreased cerebral response to inhibitory neurotransmission in alcoholics

ND Volkow, GJ Wang, R Hitzemann, JS Fowler, AP Wolf, N Pappas, A Biegon and SL Dewey
Medical Department, Brookhaven National Laboratory, Upton, NY 11973.

OBJECTIVE: Changes in gamma-aminobutyric acid (GABA)-benzodiazepine receptor function have been implicated in alcohol tolerance, withdrawal, and dependence. The purpose of this study was to investigate whether recently detoxified alcoholic subjects had abnormalities in brain GABA-benzodiazepine receptor function. METHOD: The effect of 30 micrograms/kg of lorazepam on regional brain glucose metabolism was studied in 12 normal subjects and 10 alcoholic subjects with the use of positron emission tomography and [18F]fluorodeoxyglucose. RESULTS: Lorazepam decreased whole brain glucose metabolism in both the normal subjects (13% change) and the alcoholic subjects (10% change), and the response was correlated with the concentration of lorazepam in plasma. Whereas the normal and alcoholic subjects showed similar responses to lorazepam in occipital and cerebellar metabolism, the alcoholic subjects showed significantly less of a response than the comparison subjects in the thalamus, basal ganglia, and orbitofrontal cortex. The rate of response in the orbitofrontal cortex was significantly correlated with cerebellar metabolism at baseline. CONCLUSIONS: The alcoholic subjects had a blunted response to lorazepam that was specific to certain brain regions. The association between cerebellar metabolism and response to lorazepam suggests that the cerebellum may contribute to the decreased sensitivity to lorazepam which was seen in the alcoholic subjects.


This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
G. Dom, B. Sabbe, W. Hulstijn, and W. van den Brink
Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and neuroimaging studies
The British Journal of Psychiatry, September 1, 2005; 187(3): 209 - 220.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. K. Staley, C. Gottschalk, I. L. Petrakis, R. Gueorguieva, S. O'Malley, R. Baldwin, P. Jatlow, N. P. L. G. Verhoeff, E. Perry, D. Weinzimmer, et al.
Cortical {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptors in Recovery From Alcohol Dependence: Relationship to Features of Alcohol Dependence and Cigarette Smoking
Arch Gen Psychiatry, August 1, 2005; 62(8): 877 - 888.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
J. E. Ratsma, O. Van Der Stelt, and W. B. Gunning
NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Alcohol Alcohol., November 1, 2002; 37(6): 522 - 533.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. Z. Goldstein and N. D. Volkow
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
Am J Psychiatry, October 1, 2002; 159(10): 1642 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
H. F. Moselhy, G. Georgiou, and A. Kahn
FRONTAL LOBE CHANGES IN ALCOHOLISM: A REVIEW OF THE LITERATURE
Alcohol Alcohol., September 1, 2001; 36(5): 357 - 368.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. H. Taber, R. A. Hurley, A. Abi-Dargham, and B. Porjesz
Cortical Inhibition in Alcohol Dependence
J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 173 - 176.
[Full Text] [PDF]


Home page
Cereb CortexHome page
N. D. Volkow and J. S. Fowler
Addiction, a Disease of Compulsion and Drive: Involvement of the Orbitofrontal Cortex
Cereb Cortex, March 1, 2000; 10(3): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. Abi-Dargham, J. H. Krystal, S. Anjilvel, B. E. Scanley, S. Zoghbi, R. M. Baldwin, N. Rajeevan, S. Ellis, I. L. Petrakis, J. P. Seibyl, et al.
Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]Iomazenil
Am J Psychiatry, November 1, 1998; 155(11): 1550 - 1555.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, G.-J. Wang, J. S. Fowler, R. Hitzemann, S. J. Gatley, S. S. Dewey, and N. Pappas
Enhanced Sensitivity to Benzodiazepines in Active Cocaine-Abusing Subjects: A PET Study
Am J Psychiatry, February 1, 1998; 155(2): 200 - 206.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Harris, C. F. Valenzuela, S. Brozowski, L. Chuang, K. Hadingham, and P. J. Whiting
Adaptation of gamma -Aminobutyric Acid Type A Receptors to Alcohol Exposure: Studies with Stably Transfected Cells
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 180 - 188.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
D. Hommer, P. Andreasen, D. Rio, W. Williams, U. Ruttimann, R. Momenan, A. Zametkin, R. Rawlings, and M. Linnoila
Effects of m-Chlorophenylpiperazine on Regional Brain Glucose Utilization: A Positron Emission Tomographic Comparison of Alcoholic and Control Subjects
J. Neurosci., April 15, 1997; 17(8): 2796 - 2806.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1993 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org